Varun Govil
Director Ejecutivo en Epinoma, Inc. .
Cargos activos de Varun Govil
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Epinoma, Inc.
 Epinoma, Inc. BiotechnologyHealth Technology Epinoma, Inc. is an early-stage biotechnology company based in San Carlos, CA. The company is developing a novel method to quantify epigenetic signals for early-stage cancer detection and minimal residual disease (MRD) monitoring. The company has received early backing from renowned Harvard geneticist Dr. George Church and has established a strong research collaboration with researchers at TU Dortmund. Epinoma plans to onboard early access liquid biopsy and biopharma customers in late 2022. The CEO of the company is Varun Govil. | Director Ejecutivo | - | - |
| Director Financiero/CFO | - | - | |
| Secretario Corporativo | - | - | |
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Inversor de Capital Privado | - | - |
Historial de carrera de Varun Govil
Formación de Varun Govil.
| University of California San Diego | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Chief Executive Officer | 1 |
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
Sectorial
| Consumer Services | 2 |
| Finance | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
Epinoma, Inc.
Epinoma, Inc. BiotechnologyHealth Technology Epinoma, Inc. is an early-stage biotechnology company based in San Carlos, CA. The company is developing a novel method to quantify epigenetic signals for early-stage cancer detection and minimal residual disease (MRD) monitoring. The company has received early backing from renowned Harvard geneticist Dr. George Church and has established a strong research collaboration with researchers at TU Dortmund. Epinoma plans to onboard early access liquid biopsy and biopharma customers in late 2022. The CEO of the company is Varun Govil. | Health Technology |
- Bolsa de valores
- Insiders
- Varun Govil
- Experiencia
